GT201100039A - Agentes antifúngicos - Google Patents

Agentes antifúngicos

Info

Publication number
GT201100039A
GT201100039A GT201100039A GT201100039A GT201100039A GT 201100039 A GT201100039 A GT 201100039A GT 201100039 A GT201100039 A GT 201100039A GT 201100039 A GT201100039 A GT 201100039A GT 201100039 A GT201100039 A GT 201100039A
Authority
GT
Guatemala
Prior art keywords
compounds
hydraphs
prodroges
salts
compositions
Prior art date
Application number
GT201100039A
Other languages
English (en)
Inventor
Mark L Greenlee
Wilkening Robert
Apgar James
Wildonger Kenneth James
Meng Dongfang
Parker Dann L Jr
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=41669132&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=GT201100039(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed filed Critical
Publication of GT201100039A publication Critical patent/GT201100039A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/64—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with three nitrogen atoms as the only ring hetero atoms
    • A01N43/647—Triazoles; Hydrogenated triazoles
    • A01N43/653—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4196—1,2,4-Triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J63/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms
    • C07J63/008—Expansion of ring D by one atom, e.g. D homo steroids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Agronomy & Crop Science (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Engineering & Computer Science (AREA)
  • Dentistry (AREA)
  • Wood Science & Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Environmental Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Cosmetics (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

SE DESCRIBEN NOVEDOSOS DERIVADOS DE ENFUMAFUNGINA, JUNTO CON SUS SALES, HIDRATOS Y PRODROGAS FARMACÉUTICAMENTE ACEPTABLES. TAMBIÉN SE DESCRIBEN COMPOSICIONES QUE COMPRENDEN DICHOS COMPUESTOS, MÉTODOS PARA PREPARAR DICHOS COMPUESTOS Y MÉTODOS PARA USAR DICHOS COMPUESTOS COMO AGENTES ANTIFÚNGICOS Y/O INHIBIDORES DE (1,3)-B-D-GLUCAN SINTASA. LOS COMPUESTOS DESCRITOS, SUS SALES, HIDRATOS Y PRODROGAS FARMACÉUTICAMENTE ACEPTABLES, ASÍ COMO LAS COMPOSICIONES QUE COMPRENDEN DICHAS SALES, HIDRATOS Y PRODROGAS, SON ÚTILES PARA TRATAR Y/O PREVENIR INFECCIONES FÚNGICAS Y ENFERMEDADES Y AFECCIONES ASOCIADAS.
GT201100039A 2008-08-12 2011-02-11 Agentes antifúngicos GT201100039A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US13610608P 2008-08-12 2008-08-12

Publications (1)

Publication Number Publication Date
GT201100039A true GT201100039A (es) 2013-08-21

Family

ID=41669132

Family Applications (1)

Application Number Title Priority Date Filing Date
GT201100039A GT201100039A (es) 2008-08-12 2011-02-11 Agentes antifúngicos

Country Status (31)

Country Link
EP (1) EP2326172B1 (es)
KR (1) KR101686075B1 (es)
AR (1) AR073037A1 (es)
BR (1) BRPI0912074B1 (es)
CL (1) CL2011000292A1 (es)
CO (1) CO6351686A2 (es)
CR (1) CR20110075A (es)
DK (1) DK2326172T3 (es)
DO (1) DOP2011000053A (es)
EA (1) EA018337B1 (es)
ES (1) ES2526652T3 (es)
GT (1) GT201100039A (es)
HK (1) HK1158017A1 (es)
HN (1) HN2011000404A (es)
HR (1) HRP20150009T1 (es)
IL (2) IL210975A (es)
MA (1) MA32628B1 (es)
MX (1) MX2011001656A (es)
MY (1) MY156955A (es)
NI (1) NI201100035A (es)
NZ (1) NZ590914A (es)
PE (1) PE20110676A1 (es)
PL (1) PL2326172T3 (es)
PT (1) PT2326172E (es)
RS (1) RS53731B1 (es)
SI (1) SI2326172T1 (es)
SV (1) SV2011003839A (es)
TW (1) TWI439458B (es)
UA (1) UA105639C2 (es)
WO (1) WO2010019203A1 (es)
ZA (1) ZA201100788B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA036874B1 (ru) * 2015-01-19 2020-12-30 Скайнексис, Инк. Новые соли и полиморфы scy-078
US11110102B2 (en) * 2017-04-10 2021-09-07 Scynexis, Inc. Antifungal agents used in combination
WO2019028034A1 (en) * 2017-08-04 2019-02-07 Scynexis, Inc. ANTIFUNGAL AGENTS WITH IMPROVED PH ACID ACTIVITY
JP2022519500A (ja) * 2019-01-30 2022-03-24 サイネクシス，インコーポレーテッド 真菌性骨－関節感染症を治療するためのトリテルペノイド系抗真菌薬
WO2020232037A1 (en) * 2019-05-16 2020-11-19 Scynexis, Inc. Antifungal agents, like ibrexafungerp for candida auris decolonization
EP4157356A1 (en) 2020-05-29 2023-04-05 Centre National de la Recherche Scientifique Antifungal prodrugs

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE230268T1 (de) * 1996-01-31 2003-01-15 Merck & Co Inc Fungizid
US5756472A (en) 1996-01-31 1998-05-26 Merck & Co., Inc. Antifungal agent obtained from hormonema
EP1497281A4 (en) * 2002-04-17 2005-11-02 Ranbaxy Lab Ltd AZOLE DERIVATIVES AS ANTIFUNGAL AGENTS
DK2007396T3 (da) * 2006-04-03 2013-03-18 Merck Sharp & Dohme Enfumafungin-derivat som antimykotika

Also Published As

Publication number Publication date
DOP2011000053A (es) 2011-04-30
KR101686075B1 (ko) 2016-12-13
PL2326172T3 (pl) 2015-03-31
PE20110676A1 (es) 2011-09-23
TW201011004A (en) 2010-03-16
EP2326172A4 (en) 2012-06-06
EP2326172B1 (en) 2014-10-22
MX2011001656A (es) 2011-05-25
HK1158017A1 (en) 2012-07-13
CR20110075A (es) 2011-06-03
MY156955A (en) 2016-04-15
TWI439458B (zh) 2014-06-01
AR073037A1 (es) 2010-10-06
WO2010019203A1 (en) 2010-02-18
HRP20150009T1 (hr) 2015-02-27
IL242031A0 (en) 2015-11-30
SV2011003839A (es) 2011-07-06
PT2326172E (pt) 2015-02-04
ES2526652T3 (es) 2015-01-14
BRPI0912074A2 (pt) 2018-10-02
WO2010019203A8 (en) 2011-03-17
NI201100035A (es) 2011-09-20
NZ590914A (en) 2011-11-25
MA32628B1 (fr) 2011-09-01
EA201100350A1 (ru) 2011-08-30
RS53731B1 (en) 2015-06-30
DK2326172T3 (da) 2015-01-26
BRPI0912074B1 (pt) 2021-08-03
EP2326172A1 (en) 2011-06-01
UA105639C2 (uk) 2014-06-10
CO6351686A2 (es) 2011-12-20
IL210975A (en) 2015-10-29
EA018337B1 (ru) 2013-07-30
HN2011000404A (es) 2013-09-23
IL210975A0 (en) 2011-04-28
SI2326172T1 (sl) 2015-02-27
KR20110045054A (ko) 2011-05-03
CL2011000292A1 (es) 2011-11-04
ZA201100788B (en) 2012-05-01

Similar Documents

Publication Publication Date Title
UY36907A (es) Nuevas carboxamidas de acción microbiocida
UY30498A1 (es) Nueva clase de compuestos de benzimidazolilo, sus sales, composiciones farmacéuticas conteniéndolos y aplicaciones
CR20120414A (es) Derivados de arilmetoxi isoindolina y composiciones que los comprenden y métodos para utilizar los mismos
UY30846A1 (es) Derivados de oxindol sustituidos, medicamentos que los comprenden y uso de los mismos
CL2011001658A1 (es) Compuestos derivados de sulfonamidas, moduladores de los canales de sodio; composición farmacéutica que los comprende; y su uso en el tratamiento del dolor.
CU20110235A7 (es) Derivados de imidazolidin-2-ona 1,3-disustituida como inhibidores de cyp17
UY32158A (es) Derivados heterociclicos y metodos de uso de los mismos
CL2008003284A1 (es) Compuestos derivados de 4-bencilamino-1-carboxiacil-piridina, inhibidores cetp; composicion farmaceutica que los comprende; combinacion farmaceutica; y uso en el tratamiento de enfermedades metabolicas, ateroesclerosis y cardiovasculares, entre otras.
SV2010003559A (es) Algunos derivados de 2-pirazinona y su uso como inhibidores de elastasa de los neutrofilos
CR10277A (es) Pirazolquinolonas como potentes inhibidores de parp
UY32387A (es) Ciclopentanodionas herbicidamente activas, derivados, procesos para su preparación, composiciones que las comprenden y usos de las mismas
CR9786A (es) Compuestos de bencimidazol-tiofeno
UY36713A (es) Triazoles para el tratamiento de enfermedades desmielinizantes
UY30087A1 (es) Piperazinas y piperidinas como potenciadoras de mglur5
DOP2011000134A (es) Lactamas como inhibidores de beta secretasa
GT201100039A (es) Agentes antifúngicos
GT200900309A (es) Derivados de 7-alquinil-1,8-naftiridonas, su preparacion y su aplicacion en terapeutica
UY34491A (es) La composición herbicida que contiene ácido de 4-amino-3-cloro-6- (4-cloro-2-flúor-3-metoxifenil) pyridina-2-carboxílico o los derivados de los mismos y fluroxipir o los derivados de los mismos
CR11273A (es) Derivados-2-ona disustituidos en 3, su preparacion y su aplicacion en terapeutica
AR063027A1 (es) Derivados de sulfonamida
ECSP12011837A (es) Derivados de pirazol que modulan la estearoil-coa-desaturasa
CR11584A (es) Derivados de oxindol sustituidos y uso de los mismos para el tratamiento de enfermedades dependientes de la vasopresina
DOP2019000221A (es) Derivados de pirazol como inhibidores de bromodominio
UY33092A (es) Compuestos de triazol, su uso y agentes que los contienen
ECSP13012988A (es) Derivados de tienopirimidina (2,3-d) y su uso para tratar arritmia